|4Jul 18, 4:46 PM ET

SKIBSTED RUSSELL 4

4 · Processa Pharmaceuticals, Inc. · Filed Jul 18, 2024

Insider Transaction Report

Form 4
Period: 2024-07-16
SKIBSTED RUSSELL
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2024-07-16+28,00028,000 total
    Exercise: $0.00Common Stock (28,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting of 50% on 7/16/25 and the remainder upon achievement of certain criteria.

Documents

1 file
  • 4
    form4.xmlPrimary